Your browser doesn't support javascript.
loading
The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity.
Minasian, Lori; Dimond, Eileen; Davis, Myrtle; Adhikari, Bishow; Fagerstrom, Richard; Fabian, Carol; Floyd, Justin; Unger, Joseph M; Douglas, Pamela S; Mustian, Karen M; Chow, Eric J; Lipshultz, Steven; Hundley, W Gregory; Armenian, Saro; Ky, Bonnie.
Affiliation
  • Minasian L; National Cancer Institute (NCI).
  • Dimond E; National Cancer Institute (NCI).
  • Davis M; Bristol-Myers Squibb Pharmaceutical Candidate Optimization.
  • Adhikari B; National Heart Lung and Blood Institute (NHLBI).
  • Fagerstrom R; National Cancer Institute (NCI).
  • Fabian C; University of Kansas Medical Center Cancer Center.
  • Floyd J; Cancer Care Specialists of Illinois.
  • Unger JM; Fred Hutchinson Cancer Research Center and University of Washington.
  • Douglas PS; Duke University School of Medicine.
  • Mustian KM; Wilmot Cancer Institute University of Rochester Medical Center.
  • Chow EJ; Fred Hutchinson Cancer Research Center and University of Washington.
  • Lipshultz S; University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Kaleida Health, John R. Oishei Children's Hospital, UBMD Pediatrics.
  • Hundley WG; Virginia Commonwealth University VCU Pauley Heart Center.
  • Armenian S; City of Hope Comprehensive Cancer Center.
  • Ky B; Perelman School of Medicine, University of Pennsylvania.
JACC CardioOncol ; 1(1): 105-113, 2019 Sep.
Article in En | MEDLINE | ID: mdl-32529192
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: JACC CardioOncol Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: JACC CardioOncol Year: 2019 Document type: Article